Stock Events

Stock Events

Tradr 2X Long SNPS Daily 

$22.3
17
-$0.31-1.37% Today

Statistics

Day High
22.39
Day Low
22.01
52W High
43.54
52W Low
20.6
Volume
3,524
Avg. Volume
12,093
Mkt Cap
158.98M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-2.06
-2.02
-1.99
-1.95
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-27.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNPX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen focuses on neurodegenerative diseases, directly competing with Synaptogenix's Alzheimer's and neurological disorder treatments.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly has a strong pipeline in Alzheimer's disease treatments, making it a direct competitor in the neurodegenerative space.
Annovis Bio
ANVS
Mkt Cap48.93M
Annovis Bio is engaged in developing therapies for Alzheimer's and Parkinson's diseases, directly competing with Synaptogenix.
AC Immune SA
ACIU
Mkt Cap340.03M
AC Immune SA specializes in neurodegenerative diseases, including Alzheimer's, competing in the same therapeutic area as Synaptogenix.
Anavex Life Sciences
AVXL
Mkt Cap684.57M
Anavex Life Sciences Corp. focuses on developing drugs for Alzheimer's disease, directly competing in the same field.
Athira Pharma Inc
ATHA
Mkt Cap16.39M
Athira Pharma focuses on regenerating neural health, including Alzheimer's disease treatments, competing in the same space.
Arbutus Biopharma
ABUS
Mkt Cap906.73M
Arbutus Biopharma Corporation, though primarily focused on antiviral drugs, has ventured into neurodegenerative diseases, positioning it as a potential competitor.

About

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.
Show more...
CEO
Mr. Robert Weinstein
Employees
4
Country
US
ISIN
US46092D3439

Listings

XNAS
US
TAOX
BATS
US
SNPX
BOATS
BOATS
TAOX.BOATS

0 Comments

Share your thoughts

FAQ

What is Tradr 2X Long SNPS Daily stock price today?▼
The current price of SNPX is $22.3 USD — it has decreased by -1.37% in the past 24 hours. Watch Tradr 2X Long SNPS Daily stock price performance more closely on the chart.
What is Tradr 2X Long SNPS Daily stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tradr 2X Long SNPS Daily stocks are traded under the ticker SNPX.
Is Tradr 2X Long SNPS Daily stock price growing?▼
SNPX stock has fallen by -4.97% compared to the previous week, the month change is a -15.06% fall, over the last year Tradr 2X Long SNPS Daily has showed a +827.85% increase.
What is Tradr 2X Long SNPS Daily market cap?▼
Today Tradr 2X Long SNPS Daily has the market capitalization of 158.98M
When is the next Tradr 2X Long SNPS Daily earnings date?▼
Tradr 2X Long SNPS Daily is going to release the next earnings report on June 03, 2026.
What is Tradr 2X Long SNPS Daily revenue for the last year?▼
Tradr 2X Long SNPS Daily revenue for the last year amounts to 0 USD.
What is Tradr 2X Long SNPS Daily net income for the last year?▼
SNPX net income for the last year is -27.12M USD.
How many employees does Tradr 2X Long SNPS Daily have?▼
As of April 02, 2026, the company has 4 employees.
In which sector is Tradr 2X Long SNPS Daily located?▼
Tradr 2X Long SNPS Daily operates in the Health Care sector.
When did Tradr 2X Long SNPS Daily complete a stock split?▼
The last stock split for Tradr 2X Long SNPS Daily was on April 05, 2024 with a ratio of 1:25.
Where is Tradr 2X Long SNPS Daily headquartered?▼
Tradr 2X Long SNPS Daily is headquartered in New York, US.